This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

C.R. Bard Inc (BCR)

NYSE: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) 135.40M 294.50M 689.80M 530.10M
Operating Gains/Losses -25.50M -7.10M -213.00M 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -18.00M 21.30M 23.50M 37.70M
(Increase) Decrease in Inventories -33.10M -53.90M -35.90M -25.00M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 0.00 0.00 0.00 0.00
(Decrease) Increase In Other Current Liabilities -194.70M -140.50M -800.00K -162.90M
(Increase) Decrease In Other Working Capital 8.00M 11.50M 2.40M 3.70M
Other Non-Cash Items 778.00M 387.00M 550.60M 109.60M
Net Cash From Continuing Operations 798.10M 660.00M 1.12B 661.20M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 798.10M 660.00M 1.12B 661.20M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -103.80M -139.90M -103.00M -92.00M
Acquisitions -97.40M 0.00 -197.20M -139.90M
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -31.20M -30.50M 11.90M 133.70M
Cash Provided by Financing Activities
Net Cash From Investing Activities -211.40M -163.30M -288.30M -98.20M
Issuance of Debt 0.00 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 0.00 0.00 122.00M 83.30M
Repayment of Long-Term Debt -4.00M 0.00 0.00 -5.30M
Repurchase of Capital Stock -498.70M -659.60M -738.10M -472.40M
Payment of Cash Dividends -69.40M -66.20M -66.50M -66.70M
Other Financing Charges, Net 18.00M 141.40M 19.30M 197.90M
Net Cash From Financing Activities -554.10M -584.40M -663.30M -263.20M
Effect of Exchange Rate Changes -42.20M -19.10M -1.10M 100.00K
Net Change in Cash & Cash Equivalents -9.60M -106.80M 170.60M 299.90M
BCR News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for BCR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 1 1 1 1
Hold 12 12 12 12
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

BCR Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs